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Abstract
A new and efficient three-step procedure for the synthesis of 1,6-anhydro-α-D-galactofuranose is described. The key step involves
the formation of the galactofuranosyl iodide by treatment of per-O-TBS-D-Galf with TMSI, the selective 6-O-desilylation by an
excess of TMSI, and the simultaneous nucleophilic attack of the 6-hydroxy group on the anomeric carbon, with the iodide as a good
leaving group. This compound is a good precursor for building blocks for the construction of 1→6 linkages.
Introduction
Anhydro sugars are formed by the intramolecular elimination of
a water molecule, with the simultaneous formation of a new
heterocyclic ring of different size. They are valuable intermedi-
ates not only in carbohydrate synthesis, but also as starting ma-
terials for other natural and non-natural complex products and
bioactive compounds. Among the glycosans, the anhydro sugars
involving the anomeric center in the ring formation, the 1,6-
anhydro sugars are the most common and useful building
blocks [1,2]. They can play a role in synthetic methodologies
aiming at the obtainment of regioselectively functionalized
sugars in a few steps, which could give easy access to conveni-
ent glycosyl donors and acceptors [3].
Some sugars, for example galactose, can afford not only the
pyranosic derivative 1 but also the furanosic 1,6-anhydro
derivative 2, both of which may be equipped with [3.2.1]
bicyclic skeletons (Figure 1) [1].
A variety of chemical approaches for the synthesis of 1,6-
anhydro sugars have been developed [3-10]. Two classes of
methods for the synthesis of 2 can be discriminated, the first of
which starts from free galactose (D-Gal) and afford mixtures of
1 and 2 and the second starts from a galactofuranose (D-Galf)
template conveniently derivatized. Pioneer procedures for the
synthesis of 2 involved the pyrolysis of D-Gal under reduced
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Figure 1: Possible 1,6-anydro derivatives for D-galactose.
Scheme 1: Reported synthesis of 1,6-anhydro-α-D-galactofuranose [16,17].
pressure [11,12] and the acid treatment under heating [13], with
the subsequent tedious separation from several byproducts,
including the pyranosic analogue 1. Compound 2 was thus
obtained in very low yield. More recently, 2 was obtained in
32% yield by heating with a resin as an acid catalyst. Despite
the greater smoothness of the method, byproducts were also
formed, rendering the purification difficult [14].
Compound 2 obtained by these procedures was used to afford
polymers to explore their possible applications in the field of
biochemistry and pharmacology, as their properties differ from
those of the corresponding monosaccharides, and they have a
high density of functional groups that can be modified to obtain
novel materials [14,15]. Benzylated 2 was polymerized under
cationic conditions, which afforded a material not completely
characterized, presumably formed by β-D-Galf units [15]. Free
compound 2, as well as the D-Manf and D-Glcf analogues, was
also polymerized under cationic conditions to yield a hyper-
branched polysaccharide with α- and β-linked pyranosidic and
furanosidic units [14].
On the other hand, when compound 2 was envisioned as a
D-Galf template, the synthesis was devised starting from con-
venient derivatives of D-Galf in order to avoid the presence of
1. For example, compound 2 was synthesized in the past in six
steps from galactose (Scheme 1) [16]. The 1,6-ring closure was
produced by the O-debenzylation of the 6-hydroxy group of 4
and the nucleophilic attack of this hydroxy group to C-1,
promoted by SnCl4. An optimized synthesis of 2 following this
strategy has recently been described with an overall yield of
48% comprising several column chromatography purification
steps [17].
The essential role of galactofuranose in the antigenic response
of various pathogenic microorganisms [18-20] has triggered the
interest for the development of synthetic methods for D-Galf
precursors and efficient galactofuranosylation methods [21-25].
D-Galf units have been shown to be O-glycosidically linked to
other D-Galf units by 1→6 linkages in many natural structures,
e.g., in pathogenic Mycobateria and Aspergillius spp and others
[25-28]. Benzoylated compound 5 is a good precursor of D-Galf
derivatives with differentially protected hydroxy groups at pos-
ition 1 and 6, for example the diacetyl derivative 6 obtained by
the acetolysis of 5 (Scheme 1) [16]. In this way, compound 5
would give access to donors in which the 6-position could
subsequently be manipulated for the construction of a 1→6
linkage. Based on this strategy, Ning and co-workers synthe-
sized the β-(1→6)-linked hexasaccharide 7 [29], and
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Figure 2: Examples of glycobiological tools synthesized from compound 5 [29-31].
Scheme 2: D-Galactofuranosylation by the glycosyl iodide method [32-35].
Kiessling‘s group developed the synthesis of compounds 8.used
for the characterization of GlfT2, one of the two galactofura-
nosyl transferases involved in the biosynthesis of D-Galf-
containing molecules (Figure 2) [30,31].
Our laboratory has long been involved in the development of
new galactofuranosyl derivatives and galactofuranosylation
methodologies [32]. In this context, we herein report on an effi-
cient three-step synthesis of 1,6-anhydro-α-D-galactofuranose
(2) from per-O-TBS-β-D-galactofuranose (9) as a more effi-
cient alternative to existing methods.
Results and Discussion
In the framework of our project for the development of galacto-
furanosyl derivatives and glycosylation methods, we have
reported the synthesis of per-O-TBS-β-D-galactofuranose (9), a
convenient precursor of D-Galf units, and its glycosylation via
the in situ generation of galactofuranosyl iodide 10 (Scheme 2)
[32-35]. Galactofuranosyl iodides were not previously
described, and 10 proved to be useful for the synthesis of
several D-Galf-containing molecules (Scheme 2) [32].
The reported procedure consisted in the treatment of compound
9 with 1.2 equiv of TMSI in anhydrous CH2Cl2 at 0 ºC until the
total conversion of 7 into two lower moving products was
observed by TLC: the 1-iodo intermediate 10 (Rf = 0.70, 10:1
hexane/EtOAc) and 2,3,5,6-tetra-O-TBS-α,β-D-galactofura-
nose (Rf = 0.54) formed as a result of the hydrolysis of 10 on
the silica gel plate. The addition of simple alcohols or partially
protected sugars as acceptors and EtN(iPr)2 as an acid scav-
enger led to the complete consumption of both compounds and
afforded the corresponding glycosides (Scheme 2) [32]. With an
excess of TMSI, a third product (Rf = 0.62) was formed, which
was not consumed during the reaction and was still present in
the product mixture after the work-up. The 1H NMR spectrum
of this product showed a doublet at δ 5.06 with a relatively large
J1,2 value (4.5 Hz). This signal correlated with a signal at
98.4 ppm in the 13C NMR spectrum, both indicative of the
α-configuration. Signals corresponding to C-5 and C-6 showed
similar chemical shifts. The signal corresponding to C-6
(δ 65.9) was shifted slightly downfield compared to the same
signal in compound 9 (64.7 ppm), while the signal corres-
ponding to C-5 (64.2 ppm) was significantly deshielded
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(10 ppm) with respect to C-5 of compound 9. No aglycone
signals were observed. In order to elucidate the structure of this
compound we O-desilylated it by treatment with n-Bu4NF
(TBAF) in THF [36]. The product obtained (96%) was faster
moving than galactose on TLC (Rf = 0.60, 7:1:2 n-PrOH/NH3/
H2O) and showed 1H and 13C NMR spectra coincident with the
data reported for 1,6-anhydro-α-D-galactofuranose (2) [16,37].
With the objective of optimizing the conditions for glycosyla-
tions via iodide 10, the formation of 12 was suppressed by strict
control of the TMSI amount employed.
Taking into consideration how easily compound 12 was
obtained and the versatility of anhydro sugars as intermediates
for the preparation of biologically important oligosaccharides
[3], we decided to investigate the conditions to obtain it as a
main product. We reasoned that during the treatment of 9 with
TMSI, in addition to the formation of the anomeric iodide, the
6-hydroxy group could be desilylated by the acid medium
developed during the iodide formation (10 → 11). Then, the
free 6-hydroxy group could carry out an intramolecular attack
of the anomeric carbon, with iodide as a good leaving group,
affording the 1,6-anhydro derivative 12 (Scheme 3).
Scheme 3: Synthesis of 1,6-anhydro-α-D-galactofuranose from per-O-
tert-butyldimethylsilyl-D-Galf.
By treatment of 9 with an excess of TMSI (2.25 equiv) in
CH2Cl2 at room temperature for 5 h, compound 12 was
obtained as a single product in 65% yield. Conducting the reac-
tion at low temperature instead (−20 °C), a lower moving prod-
uct was detected, presumable 11, which could not be isolated.
The use of molecular sieves, which improve the reaction of 10
with alcohols or complex acceptors [32-34], should be avoided
in this case as it slows down the reaction. Based on monitoring
the reaction by 1H NMR (CDCl3) spectroscopy we observed
that the anomeric signal of 9 (5.15 ppm, J1,2 2.6 Hz) was slowly
transformed into a broad singlet at 6.53 ppm, corresponding to
H-1 of 10 [32], followed by the transformation into the
anomeric signal of 12 (5.06 ppm, J1,2 4.5). However, the depro-
tection of the 6-hydroxy group of galactofuranosides affects the
pattern of H-6 and H-6’ in the 1H NMR spectrum, effectively
equalizing them, as was shown before [38]. During the reaction,
the pair of double-doublets of H-6 and H-6’ (3.68 and
3.54 ppm) of compound 9 [32] were transformed in a double-
doublet (3.72 ppm) and an apparent triplet (3.60 ppm), corres-
ponding to the H-6 and H-6’ of 12 [32]. In between these two
signals an intense doublet corresponding to equivalent H-6,6´
(3.58 ppm) of 11 was observed, in accordance with the behav-
ior of other free HO-galactofuranosides [38], which supports
the intermediate formation of 11.
The treatment of 9 with SnCl4 afforded compound 12, but in a
lower yield due to the O-desilylation of another hydroxy group.
The addition of BF3·OEt2 to recently formed 10 resulted in the
formation of compound 12.
Several factors favor the formation of the bicyclic system of
compound 12, such as the galactose structure itself, the pres-
ence of a good leaving group at C-1, and the electron-donating
nature of the TBS groups. Thus, while compounds 13 [38] and
14 [39] were prepared by treatment with Lewis acids of fully
protected precursors and proved to be stable and therefore
useful as synthetic intermediates, attempts to prepare com-
pound 15 by treatment with BF3·OEt2 of the persilylated
precursor failed and inevitably led to the anhydro derivative 12.
Moreover, whereas treatment with TFA/THF/H2O 90:5:2.5 of
4-nitrophenyl per-O-TBS-α-D-Araf afforded 16, 4-nitrophenyl
per-O-TBS-β-D-galactofuranoside did not lead to compound 15
under the same conditions and compound 12 was obtained
instead (Figure 3).
The O-desilylation of 12 was performed by treatment with
n-Bu4F as previously optimized [32-34], affording compound 2
in almost quantitative yield (Scheme 3).
Conclusion
In conclusion, we have described a new and concise procedure
for the synthesis of the 1,6-anhydro derivatives 2 and 12, the
key step of which proceeds by a cascade set of three consecu-
tive reactions. The method compares well to existing methods
and by avoiding cumbersome steps, such as a benzylation and
several column chromatography purifications, is an effective
approach. Compounds 2 and 12 represent profitable intermedi-
ates to easily access donors and acceptors for the synthesis of
Galf-containing molecules as biochemical tools.
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Figure 3: Furanosic derivatives with free primary hydroxy group.
Experimental
General methods
Analytical thin-layer chromatography (TLC) were performed on
Silica Gel 60 F254 (Merck) aluminum supported plates (layer
thickness 0.2 mm) with solvent systems given in the text. Visu-
alization of the spots was effected by exposure to UV light and
charring with a solution of 10% (v/v) sulfuric acid in EtOH
containing 0.5% p-anisaldehyde. Column chromatography was
carried out with Silica Gel 60 (230–400 mesh, Merck). Optical
rotations were measured with a Perkin-Elmer 343 digital
polarimeter. Nuclear magnetic resonance (NMR) spectra were
recorded with a Bruker AMX 500 spectrometer. Assignments of
1H and 13C were assisted by 2D 1H COSY and HSQC experi-
ments. High resolution mass spectra (HRMS–ESI+) were
recorded in a Bruker micrOTOF-Q II spectrometer.
2,3,5-Tri-O-tert-butyldimethylsilyl-1,6-anhydro-α-D-galacto-
furanose (12). A solution of 9 [32] (0.90 g, 1.20 mmol) in an-
hydrous CH2Cl2 (15 mL) was cooled to 0 ºC and stirred for
10 min under Ar. Then, iodotrimethylsilane (2.25 equiv,
0.38 mL, 2.70 mmol) was slowly added by using a syringe
(10 min) while stirring was continued at 0 ºC. The reaction was
allowed to reach room temperature (18–25 °C) and stirred until
TLC monitoring showed the complete transformation of 9, first
in two products with Rf = 0.70 and 0.54 (10:1 hexane-EtOAc),
then the transformation of both products in one with Rf = 0.62
(5 h). The solution was diluted with CH2Cl2 (250 mL), washed
with NaHCO3 (ss) and water, dried (Na2SO4), and concen-
trated. The residue was purified by column chromatography
(98.6:1.4 → 2:1, hexane–EtOAc) affording compound 12 as an
amorphous solid (0.272 g, 65%). The analytical data of 12 were
identical with those described in ref. [32]: [α]D +42 (c 1,
CHCl3); 1H NMR (500 MHz, CDCl3) δ 5.05 (d, J = 4.5 Hz, 1H,
H-1), 4.20 (d, J = 1.8 Hz, 1H, H-3), 4.15 (dd, J = 1.8, 4.5 Hz,
1H, H-2), 3.97 (ddd, J = 4.3, 6.3, 10.5 Hz, 1H, H-5), 3.91
(broad d, J = 4.0 Hz, 1H, H-4), 3.72 (ddd, J = 1.5, 6.2, 10.5 Hz,
1H, H-6), 3.60 (apparent t, J = 10.7 Hz, 1H, H-6′), 0.94–0.86
(SiC(CH3)3), 0.12–0.04 (Si(CH3)2); 13C NMR (125,8 MHz,
CDCl3) δ 98.4 (C-1), 85.3 (C-4), 83.2 (C-2), 77.6 (C-3), 65.9
(C-6), 64.2 (C-5), 25.84, 25.89, 25.6 (SiC(CH3)3), 17.9
(SiC(CH3)3), −4.49, −4.57, −4.64, −4.68, −4.93, −5.02
(Si(CH3)2); Anal. calcd for C24H52O5Si3: C, 57.09; H, 10.38;
found: C, 56.90; H, 10.52.
1,6-Anhydro-α-D-galactofuranose (2). To a solution of 12
(0.12 g, 0.22 mmol) in freshly distilled THF (7 mL), cooled at
0 °C, (n-Bu)4NF (12 equiv, 2.32 g, 8.88 mmol) was added [36].
The solution was allowed to reach room temperature and then
stirring was continued for 3 h until TLC monitoring showed the
complete consumption of the starting material. The solution was
diluted with water (50 mL), extracted with CH2Cl2 (2 × 30 mL),
and the aqueous phase was concentrated under vacuum. Purifi-
cation of the residue by column chromatography (20:1 AcOEt/
hexane) afforded 2 (0.036 g, 95%), [α]D +54 (c 1.0, H2O), lit.
[16] [α]D +54; 1H NMR (500 MHz, D2O) δ 5.31 (d, J = 4.6 Hz,
1H, H-1), 4.26–4.23 (m, 2H, H-2, H-3), 4.19 (broad d, J = 4.2
Hz, 1H, H-4), 4.08–3.99 (m, 2H, H-5, H-6), 3.55 (apparent t, J
= 10.4 Hz, 1H, H-6′); 13C NMR (125.8 MHz, D2O) δ 98.6
(C-1), 85.2 (C-4), 80.9 (C-2), 75.4 (C-3), 65.6 (C-6), 62.7 (C-5).
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